Data on Real-World Use of Belantamab Mafodotin in R/R MM

Dr Shonali Midha continues her analysis of belantamab mafodotin with a look at data on real-world use in R/R MM since its FDA approval in August 2020.

Related Videos
Experts on MM
Experts on multiple myeloma
Experts on MM
Experts on multiple myeloma
Related Content